The molecular mechanisms of the thrombotic complications of atherosclerosis

Journal of Internal Medicine

Volumn 263, Issue 5, 2008, Pages 517-527

  Libby, P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cathepsin; Collagen; Extracellular matrix; Fibrous cap; Matrix metalloproteinase; Plaque rupture

Indexed keywords

MATRIX METALLOPROTEINASE;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CORONARY ARTERY THROMBOSIS; INFLAMMATION; MOLECULAR IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOGENICITY; THROMBOSIS;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; COLLAGEN; CORONARY THROMBOSIS; ENDOTHELIUM, VASCULAR; HUMANS; LIPIDS; MATRIX METALLOPROTEINASES; MICE; RUPTURE, SPONTANEOUS;

EID: 42149099498     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01965.x     Document Type: Conference Paper

References (52)

1. Libby P. Changing concepts of atherogenesis. J Intern Med 2000 247 : 349 58.
2. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995 92 : 657 71.
3. Davies MJ. Stability and instability: the two faces of coronary atherosclerosis. The Paul Dudley White Lecture, 1995. Circulation 1996 94 : 2013 20.
4. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005 111 : 3481 8.
5. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006 47 : C13 8.
6. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate intersitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1991 11 : 1223 30.
7. Hansson GK, Jonasson L, Holm J, Claesson-Welsh L. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol 1986 64 : 261 8.
8. Warner SJC, Friedman GB, Libby P. Regulation of major histocompatibility gene expression in cultured human vascular smooth muscle cells. Arteriosclerosis 1989 9 : 279 88.
9. Rekhter M, Zhang K, Narayanan A, Phan S, Schork M, Gordon D. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J Pathol 1993 143 : 1634 48.
10. Libby P. The molecular bases of the acute coronary syndromes. Circulation 1995 91 : 2844 50.
11. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994 94 : 2493 503.
12. Nikkari ST, O'Brien KD, Ferguson M et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995 92 : 1393 8.
13. Sukhova GK, Schonbeck U, Rabkin E et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999 99 : 2503 9.
14. Herman MP, Sukhova GK, Libby P et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001 104 : 1899 904.
15. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998 102 : 576 83.
16. Dollery CM, Owen CA, Sukhova GK, Krettek A, Shapiro SD, Libby P. Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation 2003 107 : 2829 36.
17. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004 24 : 1359 66.
18. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1995 748 : 501 7.
19. Fabunmi RP, Sukhova GK, Sugiyama S, Libby P. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res 1998 83 : 270 8.
20. Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006 69 : 625 35.
21. Fukumoto Y, Deguchi JO, Libby P et al. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. Circulation 2004 110 : 1953 9.
22. Deguchi JO, Aikawa E, Libby P et al. Matrix metalloproteinase-13/ collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation 2005 112 : 2708 15.
23. Schneider F, Sukhova GK, Aikawa M et al. Matrix metalloproteinase-14 deficiency in bone marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 2008 117 : 931 9.
24. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989 86 : 2839 43.
25. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989 134 : 1087 97.
26. Nemerson Y, Giesen PL. Some thoughts about localization and expression of tissue factor. Blood Coagul Fibrinolysis 1998 9 : S45 7.
27. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 1991 174 : 1517 26.
28. Mach F, Schoenbeck U, Bonnefoy J-Y, Pober J, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin, and tissue factor. Circulation 1997 96 : 396 9.
29. Henn V, Slupsky JR, Grafe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998 391 : 591 4.
30. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation 2001 103 : 1718 20.
31. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 2007 14 : 55 61.
32. Libby P, Ganz P, Schoen FJ, Lee RT. The vascular biology of the acute coronary syndromes. In : Topol EJ, ed. Acute Coronary Syndromes. New York : Marcel Dekker, Inc., 2000 33 57.
33. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001 158 : 879 91.
34. Baldus S, Heeschen C, Meinertz T et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003 108 : 1440 5.
35. Brennan ML, Penn MS, Van Lente F et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003 349 : 1595 604.
36. Meuwese MC, Stroes ES, Hazen SL et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007 50 : 159 65.
37. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994 94 : 437 44.
38. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004 24 : 1309 14.
39. Galis Z, Muszynski M, Sukhova G et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994 75 : 181 9.
40. Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996 157 : 4159 65.
41. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994 370 : 61 5.
42. Rajavashisth TB, Liao JK, Galis ZS et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999 274 : 11924 9.
43. Thomas AC, Knapman PA, Krikler DM, Davies MJ. Community study of the causes of "natural" sudden death. BMJ 1988 297 : 1453 6.
44. Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988 60 : 459 64.
45. Jaffer FA, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation 2007 116 : 1052 61.
46. Deguchi J, Aikawa M, Tung C-H et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006 114 : 55 62.
47. Jaffer FA, Kim DE, Quinti L et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 2007 115 : 2292 8.
48. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002 8 : 1257 62.
49. Libby P, Ridker PM. Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol 2006 48 : A33 46.
50. Ridker PM, Cannon CP, Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005 352 : 20 8.
51. Morrow DA, de Lemos JA, Sabatine MS et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation 2006 114 : 281 8.
52. Libby P. Inflammation in cardiovascular disease. In : Morrow DA, ed. Contemporary Cardiology. Totowa, NJ : Humana Press, Inc., 2006 205 19.